Ad
related to: Vertex
Search results
Vertex, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Simply Wall St. via Yahoo Finance· 5 hours agoIt's been a good week for Vertex, Inc. (NASDAQ:VERX) shareholders, because the company has just...
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by StockNews.com
ETF DAILY NEWS· 15 hours agoBarclays lifted their target price on Vertex Pharmaceuticals from $446.00 to $472.00 and gave the stock an “overweight” rating in a report on Tuesday, February 6th. Wolfe ...
Vertex Energy, Inc. (NASDAQ:VTNR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 22 hours agoVertex Energy, Inc. (NASDAQ:VTNR) Q1 2024 Earnings Call Transcript May 9, 2024 Vertex Energy, Inc....
Vertex shares target raised by RBC on robust CF sales By Investing.com
Investing.com· 4 days agoOn Tuesday, RBC (TSX:RY) Capital Markets adjusted its price target for Vertex Pharmaceuticals...
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
GuruFocus.com via Yahoo Finance· 5 days agoStrategic Acquisition: Announced the acquisition of Alpine Immune Sciences, enhancing the pipeline...
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
Zacks via Yahoo Finance· 4 days agoVertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Earnings call: Vertex Pharmaceuticals reports solid Q1 growth, plans expansion
Investing.com· 5 days agoVertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) has reported a robust 13% year-over-year revenue...
Vertex Energy First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 1 day agoVertex Energy (NASDAQ:VTNR) First Quarter 2024 Results Key Financial Results Revenue: US$695.3m...
Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
Investor's Business Daily· 4 days agoVertex stock advanced Tuesday as analysts debated the company's pain drug, VX-548, with one saying...